Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Debt Ratio (2022 - 2025)

Cue Biopharma's Debt Ratio history spans 4 years, with the latest figure at 0.05 for Q3 2025.

  • For Q3 2025, Debt Ratio fell 56.2% year-over-year to 0.05; the TTM value through Sep 2025 reached 0.05, down 56.2%, while the annual FY2024 figure was 0.13, 1.43% up from the prior year.
  • Debt Ratio for Q3 2025 was 0.05 at Cue Biopharma, down from 0.06 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.15 in Q1 2025 and bottomed at 0.05 in Q3 2025.
  • The 4-year median for Debt Ratio is 0.13 (2022), against an average of 0.12.
  • The largest annual shift saw Debt Ratio rose 21.16% in 2023 before it plummeted 56.64% in 2025.
  • A 4-year view of Debt Ratio shows it stood at 0.11 in 2022, then rose by 21.16% to 0.13 in 2023, then increased by 1.43% to 0.13 in 2024, then crashed by 61.31% to 0.05 in 2025.
  • Per Business Quant, the three most recent readings for CUE's Debt Ratio are 0.05 (Q3 2025), 0.06 (Q2 2025), and 0.15 (Q1 2025).